Stem Cells International

Advances in Induced Pluripotent Stem Cell Technologies


Publishing date
15 Mar 2012
Status
Published
Submission deadline
15 Sep 2011

Lead Editor

1Manipal Institute of Regenerative Medicine, Manipal University Branch Campus, Bangalore-560 071, India

2Buck Institute for Age Research, Novato, CA, USA

3Life Technologies, Frederick, MD, USA

4Monash Institute of Medical Research, Clayton, VIC 3168, Australia


Advances in Induced Pluripotent Stem Cell Technologies

Description

The year 2006 marked the beginning of a new era in regenerative biology when Yamanaka and colleagues successfully reprogrammed mouse and human fibroblasts to induced pluripotent stem (iPS) cells with qualities strikingly identical with embryonic stem (ES) cells. This breakthrough enriched the armamentarium of regenerative medicine by introducing autologous pluripotent progenitor pools for drug discovery, cell therapy, and basic research. iPS cell technology which uses defined transcription factors to reprogram somatic cells into pluripotent state also offers a significant technical simplicity and enables generation of patient- and disease- specific stem cells with reduced ethical concerns. Despite functional similarity between iPS and ES cells, some important differences were also identified and remain to be characterized. Meanwhile, new methods of generating iPS cells with minimal or no exogenous genetic modifications to cells including direct conditioning of cells to differentiated fates have advanced rapidly. Any improvement in iPS cell-based technology will ensure robust applications across discovery science, offering opportunities for the development of personalized diagnostics and targeted therapeutics. The field of regenerative medicine is primed to adopt and incorporate iPS cell-based advancements as next generation stem cell platforms.

However, there remain a great deal to learn about iPS cell safety, the reprogramming mechanisms, and better ways to direct a specific reprogramming process. The flourish of this field heavily depends on the success of in vitro disease modeling and establishment of new culture conditions including identification of new small molecules that modulate reprogramming. Attempts to fine tune this cutting-edge technology by avoiding the employment of retroviral/lentiviral vectors as well as optimizing the reprogramming cocktail are progressing at an astonishing pace worldwide. Therefore, we are optimistic that this could be an area where novelty and therapeutic significance would never be over rated. We believe that this special issue will provide a lucid picture of the bright future for this technology through expert perspectives. The journal “Stem Cell International” is uniquely poised to deal with this new age of stem cell research. To demonstrate this fact, we invite researchers to contribute original research articles, and reviews which will stimulate the future investigations. Potential topics include, but are not limited to:

  • Newer and safer methods to make iPS cells
  • Novel sources to generate iPS cells
  • Molecular networks underpinning pluripotency
  • Lineage-specific differentiation and characterization
  • Epigenetic mechanisms
  • Regulatory and safety aspects
  • Drug discovery models and studies on toxicity testing
  • Cell therapy applications
  • Personalized medicine aspects

Articles published in this special issue will not be subject to the journal's Article Processing Charges.

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/sci/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 850201
  • - Editorial

Advances in Induced Pluripotent Stem Cell Technologies

Rajarshi Pal | Mahendra Rao | ... | Andras Dinnyes
  • Special Issue
  • - Volume 2012
  • - Article ID 926463
  • - Research Article

Laser-Based Propagation of Human iPS and ES Cells Generates Reproducible Cultures with Enhanced Differentiation Potential

Kristi A. Hohenstein Elliott | Cory Peterson | ... | Gary R. Bright
  • Special Issue
  • - Volume 2012
  • - Article ID 549846
  • - Research Article

Cellular Reprogramming Employing Recombinant Sox2 Protein

Marc Thier | Bernhard Münst | ... | Frank Edenhofer
  • Special Issue
  • - Volume 2012
  • - Article ID 365932
  • - Review Article

Cell Reprogramming, IPS Limitations, and Overcoming Strategies in Dental Bioengineering

Gaskon Ibarretxe | Antonia Alvarez | ... | Fernando Unda
  • Special Issue
  • - Volume 2012
  • - Article ID 423868
  • - Review Article

The Promise of Human Induced Pluripotent Stem Cells in Dental Research

Thekkeparambil Chandrabose Srijaya | Padmaja Jayaprasad Pradeep | ... | Vijayendran Govindasamy
  • Special Issue
  • - Volume 2012
  • - Article ID 379569
  • - Review Article

Drug Discovery Models and Toxicity Testing Using Embryonic and Induced Pluripotent Stem-Cell-Derived Cardiac and Neuronal Cells

Rahul S. Deshmukh | Krisztián A Kovács | András Dinnyés
  • Special Issue
  • - Volume 2012
  • - Article ID 541014
  • - Research Article

Temporal Requirements of cMyc Protein for Reprogramming Mouse Fibroblasts

Corey Heffernan | Huseyin Sumer | ... | Paul J. Verma
  • Special Issue
  • - Volume 2012
  • - Article ID 767195
  • - Review Article

Nonhuman Primate Induced Pluripotent Stem Cells in Regenerative Medicine

Yuehong Wu | Anuja Mishra | ... | Peter J. Hornsby
  • Special Issue
  • - Volume 2012
  • - Article ID 140427
  • - Research Article

Small Molecules Greatly Improve Conversion of Human-Induced Pluripotent Stem Cells to the Neuronal Lineage

Sally K. Mak | Y. Anne Huang | ... | Birgitt Schüle
  • Special Issue
  • - Volume 2012
  • - Article ID 431534
  • - Research Article

High-Resolution Genomic Profiling of Chromosomal Abnormalities in Human Stem Cells Using the 135 K StemArray

Aaron M. Elliott | Kristi A. Hohenstein Elliott | Anja Kammesheidt
Stem Cells International
 Journal metrics
See full report
Acceptance rate15%
Submission to final decision153 days
Acceptance to publication27 days
CiteScore8.500
Journal Citation Indicator0.800
Impact Factor4.3
 Submit Check your manuscript for errors before submitting

Article of the Year Award: Impactful research contributions of 2022, as selected by our Chief Editors. Discover the winning articles.